Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer

Qianze Dong; Lin Fu; Yue Zhao; Yaming Du; Qingchang Li; Xueshan Qiu; Enhua Wang

doi:10.18632/oncotarget.15359

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer

Qianze Dong, Lin Fu, Yue Zhao, Yaming Du, Qingchang Li, Xueshan Qiu and Enhua Wang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:27800-27811. https://doi.org/10.18632/oncotarget.15359

Metrics: PDF 3709 views | HTML 3294 views | ?

Abstract

Qianze Dong1, Lin Fu1, Yue Zhao1, Yaming Du2, Qingchang Li1, Xueshan Qiu1, Enhua Wang1

1Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China

2Department of Cardiovascular Thoracic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China

Correspondence to:

Enhua Wang, email: [email protected]

Keywords: Rab11a, Hippo, YAP, non-small cell lung cancer, proliferation

Received: October 26, 2016 Accepted: January 09, 2017 Published: February 15, 2017

ABSTRACT

Rab11a, an evolutionarily conserved Rab GTPases, plays important roles in intracellular transport and has been implicated in cancer progression. However, its role in human non-small cell lung cancer (NSCLC) has not been explored yet. In this study, we discovered that Rab11a protein was upregulated in 57/122 NSCLC tissues. Rab11a overexpression associated with advanced TNM stage, positive nodal status and poor patient prognosis. Rab11a overexpression promoted proliferation, colony formation, invasion and migration with upregulation of cyclin D1, cyclin E, and downregulation of p27 in NSCLC cell lines. Nude mice xenograft demonstrated that Rab11a promoted in vivo cancer growth. Importantly, we found that Rab11a induced YAP protein and inhibited Hippo signaling. Depletion of YAP abolished the effects of Rab11a on cell cycle proteins and cell proliferation. Furthermore, immunoprecipitation showed that Rab11a interacted with YAP in lung cancer cells. In conclusion, the present study suggestes that Rab11a serves as an important oncoprotein and a regulator of YAP in NSCLC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15359

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer

Abstract